Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Saving pediatric cancer drugs from the ‘valley of death’
Beckers Hospital Review
Fri, 05/16/25 - 11:23 am
cancer
pediatric
oncology
drug development
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
UK unveils £1B plan to become leading cancer research hub just outside the Golden Triangle
Fierce Biotech
Fri, 05/2/25 - 11:19 am
London
UK
R&D
cancer
AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent
Pharmaphorum
Tue, 04/29/25 - 08:11 am
AACR
Ascentage Pharma
oncology
cancer
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff
BioPharma Dive
Fri, 04/25/25 - 11:19 am
Caribou Biosciences
CRISPR
layoffs
lupus
cancer
cell therapy
Mosaic adds to cancer combo pattern by licensing 2 clinical-stage drugs from Astex
Fierce Biotech
Thu, 04/24/25 - 10:50 am
Mosaic Therapeutics
Astex Pharmaceuticals
cancer
oncology
German cancer antibody biotech eyes SPAC as route to Nasdaq
Fierce Biotech
Wed, 04/23/25 - 11:02 am
Veraxa
SPACs
NASDAQ
cancer
Boehringer to expand oncology presence with $572m Tessellate Bio deal
Pharmaceutical Technology
Wed, 04/23/25 - 09:42 am
Boehringer Ingelheim
Tessellate Bio
cancer
oncology
telomeres
Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio
Xtalks
Sun, 04/13/25 - 11:15 pm
Jobevne
bevacizumab-nwgd
Biocon Biologics
biosimilars
Avastin
cancer
FDA
As Trump Cuts Cancer Research Funding, Billionaire Sean Parker Wants To Scale It Up
Forbes
Mon, 03/31/25 - 10:53 am
Sean Parker
funding
cancer
Parker Institute for Cancer Immunotherapy
FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again
Fierce Pharma
Sun, 03/23/25 - 11:43 pm
Jiangsu Hengrui
Elevar Therapeutics
camrelizumab
FDA
cancer
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Fri, 03/21/25 - 11:42 am
gene therapy
rare disease
cancer
obesity
weight loss
drug development
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune
Fierce Biotech
Thu, 03/20/25 - 11:11 am
Century Therapeutics
cell therapy
cancer
autoimmune diseases
Lilly backs precision medicine start-up’s $65 million raise
Chemical and Engineering News
Wed, 03/19/25 - 11:16 am
Ampersand Biosciences
Eli Lilly
funding
cancer
Flagship Pioneering
Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash
Fierce Biotech
Tue, 03/18/25 - 11:17 am
Nanobiotix
JNJ
cancer
JNJ-1900
head and neck cancer
AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama
Fierce Pharma
Mon, 03/17/25 - 10:11 pm
AstraZeneca
Alteogen
oncology
cancer
subcutaneous drug delivery
Labcorp is buying Bioreference health’s cancer testing business for $192m
MedCity News
Sun, 03/16/25 - 09:52 pm
Medtech
diagnostics
M&A
LabCorp
BioReference Labs
cancer
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
Motley Fool
Thu, 03/13/25 - 11:32 am
Summit Therapeutics
ivonescimab
cancer
non-small cell lung cancer
Everest Medicines begins dosing in mRNA cancer vaccine trial
Clinical Trials Arena
Fri, 03/7/25 - 11:02 am
Everest Medicines
EVM16
MRNA
cancer vaccines
cancer
clinical trials
Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck
MSN/Bloomberg
Wed, 03/5/25 - 11:26 pm
Moderna Therapeutics
Merck
cancer
vaccines
cancer vaccine
clinical trials
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »